Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001493152-21-004174

Options or other derivatives

  • CEO and Chairman acquired 1,368,999 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Johnson David Ian CEO and Chairman 2021-02-15 Grant or award · Restricted Stock Units +1,315,807 1,315,807 D
Johnson David Ian CEO and Chairman 2021-02-15 Grant or award · Restricted Stock Units +53,192 1,368,999 D
Loading xslF345X03/ownership.xml…